A platinum-based hybrid drug design approach to circumvent acquired resistance to molecular targeted tyrosine kinase inhibitors
基于铂的混合药物设计方法可避免对分子靶向酪氨酸激酶抑制剂的获得性耐药性
期刊:Scientific Reports
影响因子:3.8
doi:10.1038/srep25363
Yuming Wei, Daniel C Poon, Rong Fei, Amy S M Lam, Steve C F Au-Yeung, Kenneth K W To
